Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2012-07-13 Interim / Quarterly Rep…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-June 2012. It contains comprehensive financial statements, including income statements, cash flow data, and balance sheet summaries, as well as detailed management commentary (VD-kommentar) and project portfolio updates. It is not an announcement of a report, but the report itself, containing substantive financial data. H1 2012
2012-07-13 Swedish
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY–JUNE 2012' and contains comprehensive financial statements, including net sales, net loss, cash flow, and balance sheet data for the specified period. It also includes a CEO commentary, project portfolio updates, and detailed financial tables. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2012
2012-07-13 English
KARO BIO ANNUAL GENERAL MEETING
AGM Information Classification · 98% confidence The document explicitly states in the title and content that it pertains to the 'KARO BIO ANNUAL GENERAL MEETING' and details the resolutions passed there, such as dividend decisions, board elections, and authorizations. This directly aligns with the definition of 'AGM Information' (Code: AGM-R). Although it contains elements that might touch upon director changes (MANG) or share authorization (SHA/CAP), the overarching context is the summary of the meeting itself.
2012-06-13 English
ÅRSSTÄMMA KARO BIO
AGM Information Classification · 99% confidence The document is titled "ÅRSSTÄMMA KARO BIO" (Annual General Meeting Karo Bio) and details decisions made during the meeting held on June 12, 2012. It covers resolutions regarding dividends, board member elections, auditor appointments, remuneration guidelines, and authorization for share issuance. These topics are central to the proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R).
2012-06-13 Swedish
KARO BIO GENOMFÖR PLANERAD EFFEKTIVISERING
Earnings Release Classification · 99% confidence The document is a short press release dated May 31, 2012, announcing internal restructuring, staff reductions, and future financing goals for Karo Bio AB. It is not a full financial report (like 10-K or IR), nor is it a specific regulatory filing like a Director's Dealing or a Dividend Notice. It announces operational changes and financial outlook, which aligns best with a general corporate announcement. Since it is a press release detailing operational and strategic updates, and it doesn't fit the specific categories like ER (Earnings Release, which focuses on results), the most appropriate general category for a corporate update that isn't a specific mandated filing is Regulatory Filings (RNS), as it is a public disclosure required by market regulations ('Informationen är sådan som Karo Bio är skyldigt att offentliggöra enligt lagen om värdepappersmarknaden'). Given the content is an operational efficiency announcement rather than a financial result, RNS serves as the best fit among the provided options for a general regulatory disclosure. FY 2012
2012-05-31 Swedish
KARO BIO IMPLEMENTS PLANNED EFFICIENCY MEASURES
Regulatory Filings Classification · 99% confidence The document is a short press release titled "KARO BIO IMPLEMENTS PLANNED EFFICIENCY MEASURES" announcing staff reductions and strategic goals. It is dated May 31, 2012, and concludes by stating that the information was published in accordance with Swedish securities laws and is available online. This format—a brief announcement of corporate news that is not a formal financial report (like 10-K or IR) or a specific transaction report (like DIV or DIRS)—fits best under the general category for miscellaneous regulatory announcements or press releases that don't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) serves as the appropriate fallback for general corporate news announcements that are not explicitly defined elsewhere, especially since it is a standard press release format.
2012-05-31 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.